会員登録
ログイン
【2784】アルフレッサ ホールディングス
医薬品卸。国内1位。
類似企業：
【業界1位】
メディパルホールディングス
【業界1位】
メディパルホールディングス
売上高
営業利益
経常利益
当期利益
業績予想修正
対前回修正率
当初予想比較
| 決算期 | 日付 | 予・実 | 売上高 (百万円) | 対前回 | 営業利益 (百万円) | 対前回 | 経常利益 (百万円) | 対前回 | 当期利益 (百万円) | 対前回 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025.03 | 2025/02/10 | Q3予 | 2,965,000 | → | 37,300 | → | 40,000 | → | 28,000 | → |
| 2025.03 | 2024/11/07 | Q2予 | 2,965,000 | → | 37,300 | → | 40,000 | → | 28,000 | ↑ |
| 2025.03 | 2024/08/05 | Q1予 | 2,965,000 | → | 37,300 | → | 40,000 | → | 26,000 | → |
| 2025.03 | 2024/05/14 | 当初予 | 2,965,000 | - | 37,300 | - | 40,000 | - | 26,000 | - |
| 2024.03 | 2024/05/14 | 実 | 2,858,500 | → | 38,460 | ↑ | 39,997 | ↓ | 29,558 | ↑ |
| 2024.03 | 2024/04/30 | 修正予 | 2,858,500 | ↓ | 38,400 | ↑ | 40,000 | ↑ | 29,500 | ↑ |
| 2024.03 | 2024/02/08 | Q3予 | 2,860,000 | → | 36,000 | → | 38,000 | → | 24,900 | → |
| 2024.03 | 2023/11/07 | Q2予 | 2,860,000 | → | 36,000 | → | 38,000 | → | 24,900 | → |
| 2024.03 | 2023/10/31 | 修正予 | 2,860,000 | ↑ | 36,000 | ↑ | 38,000 | ↑ | 24,900 | ↑ |
| 2024.03 | 2023/08/08 | Q1予 | 2,744,000 | → | 32,000 | → | 34,000 | → | 22,000 | → |
| 2024.03 | 2023/05/15 | 当初予 | 2,744,000 | - | 32,000 | - | 34,000 | - | 22,000 | - |
| 2023.03 | 2023/05/15 | 実 | 2,696,069 | ↓ | 30,148 | ↑ | 32,831 | ↑ | 25,786 | ↑ |
| 2023.03 | 2023/04/28 | 修正予 | 2,698,000 | ↑ | 30,100 | ↑ | 32,800 | → | 25,700 | ↑ |
| 2023.03 | 2023/02/07 | Q3予 | 2,618,000 | → | 29,500 | → | 32,800 | → | 21,200 | → |
| 2023.03 | 2022/11/07 | Q2予 | 2,618,000 | → | 29,500 | → | 32,800 | → | 21,200 | → |
| 2023.03 | 2022/08/05 | Q1予 | 2,618,000 | → | 29,500 | → | 32,800 | → | 21,200 | → |
| 2023.03 | 2022/05/16 | 当初予 | 2,618,000 | - | 29,500 | - | 32,800 | - | 21,200 | - |
| 2022.03 | 2022/05/16 | 実 | 2,585,643 | ↑ | 29,091 | ↑ | 32,576 | ↑ | 32,182 | ↑ |
| 2022.03 | 2022/04/28 | 修正予 | 2,585,000 | ↑ | 29,000 | ↑ | 32,400 | ↑ | 32,100 | ↑ |
| 2022.03 | 2022/02/07 | Q3予 | 2,578,000 | → | 21,900 | → | 25,500 | → | 29,000 | ↑ |
| 2022.03 | 2021/11/04 | Q2予 | 2,578,000 | ↑ | 21,900 | ↓ | 25,500 | ↓ | 17,000 | ↓ |
| 2022.03 | 2021/08/05 | Q1予 | 2,505,000 | → | 28,300 | → | 31,700 | → | 20,700 | → |
| 2022.03 | 2021/05/14 | 当初予 | 2,505,000 | - | 28,300 | - | 31,700 | - | 20,700 | - |
| 2021.03 | 2021/05/14 | 実 | 2,603,169 | ↑ | 20,672 | ↑ | 31,918 | ↑ | 24,501 | ↑ |
| 2021.03 | 2021/04/30 | 修正予 | 2,603,000 | ↓ | 20,600 | ↓ | 20,600 | ↓ | 24,500 | ↑ |
| 2021.03 | 2021/02/08 | Q3予 | 2,631,000 | → | 20,900 | → | 31,300 | → | 19,600 | → |
| 2021.03 | 2020/11/05 | Q2予 | 2,631,000 | → | 20,900 | → | 31,300 | → | 19,600 | → |
| 2021.03 | 2020/08/05 | Q1予 | 2,631,000 | ↓ | 20,900 | ↓ | 31,300 | ↓ | 19,600 | ↓ |
| 2021.03 | 2020/05/12 | 当初予 | 2,700,000 | - | 36,800 | - | 47,200 | - | 30,200 | - |
| 2020.03 | 2020/05/12 | 実 | 2,698,511 | ↑ | 47,645 | ↑ | 57,170 | ↑ | 40,273 | ↑ |
| 2020.03 | 2020/02/07 | Q3予 | 2,680,000 | → | 45,400 | → | 55,600 | → | 37,600 | → |
| 2020.03 | 2019/11/06 | Q2予 | 2,680,000 | → | 45,400 | → | 55,600 | → | 37,600 | → |
| 2020.03 | 2019/08/05 | Q1予 | 2,680,000 | → | 45,400 | → | 55,600 | → | 37,600 | → |
| 2020.03 | 2019/05/15 | 当初予 | 2,680,000 | - | 45,400 | - | 55,600 | - | 37,600 | - |
| 2019.03 | 2019/05/15 | 実 | 2,640,511 | ↑ | 44,770 | ↑ | 55,125 | ↑ | 41,699 | ↑ |
| 2019.03 | 2019/02/04 | Q3予 | 2,630,000 | → | 41,900 | → | 51,900 | → | 39,000 | → |
| 2019.03 | 2018/11/05 | Q2予 | 2,630,000 | → | 41,900 | → | 51,900 | → | 39,000 | → |
| 2019.03 | 2018/10/29 | 修正予 | 2,630,000 | ↑ | 41,900 | ↑ | 51,900 | ↑ | 39,000 | ↑ |
| 2019.03 | 2018/08/03 | Q1予 | 2,610,000 | → | 35,600 | - | 45,700 | → | 33,000 | → |
| 2019.03 | 2018/05/11 | 当初予 | 2,610,000 | - | - | - | 45,700 | - | 33,000 | - |
| 2018.03 | 2018/05/11 | 実 | - | - | - | - | - | - | - | - |
| 2018.03 | 2018/04/27 | 修正予 | 2,602,000 | ↑ | - | - | 51,800 | ↑ | 35,500 | ↑ |
| 2018.03 | 2018/02/06 | Q3予 | 2,595,000 | → | 34,200 | → | 44,600 | → | 29,900 | → |
| 2018.03 | 2017/11/06 | Q2予 | 2,595,000 | → | 34,200 | → | 44,600 | → | 29,900 | → |
| 2018.03 | 2017/08/04 | Q1予 | 2,595,000 | → | 34,200 | → | 44,600 | → | 29,900 | → |
| 2018.03 | 2017/05/12 | 当初予 | 2,595,000 | - | 34,200 | - | 44,600 | - | 29,900 | - |
| 2017.03 | 2017/05/12 | 実 | 2,551,801 | ↓ | 33,228 | ↑ | 43,628 | ↑ | 30,893 | ↑ |
| 2017.03 | 2017/02/07 | Q3予 | 2,572,000 | → | 30,000 | → | 40,200 | → | 28,300 | → |
| 2017.03 | 2016/11/04 | Q2予 | 2,572,000 | ↓ | 30,000 | ↓ | 40,200 | ↓ | 28,300 | ↓ |
| 2017.03 | 2016/08/04 | Q1予 | 2,623,000 | → | 37,900 | → | 47,600 | → | 30,300 | → |
| 2017.03 | 2016/05/11 | 当初予 | 2,623,000 | - | 37,900 | - | 47,600 | - | 30,300 | - |
| 2016.03 | 2016/05/11 | 実 | 2,576,405 | ↑ | 45,289 | ↑ | 55,489 | ↑ | 34,975 | ↑ |
| 2016.03 | 2016/04/28 | 修正予 | 2,576,000 | ↓ | 45,200 | ↑ | 55,400 | ↑ | 34,600 | ↑ |
| 2016.03 | 2016/02/05 | Q3予 | 2,577,000 | ↑ | 37,200 | ↑ | 47,000 | ↑ | 29,500 | ↑ |
| 2016.03 | 2015/11/05 | Q2予 | 2,526,000 | → | 30,900 | → | 40,600 | → | 23,800 | → |
| 2016.03 | 2015/08/05 | Q1予 | 2,526,000 | → | 30,900 | - | 40,600 | → | 23,800 | → |
| 2016.03 | 2015/05/11 | 当初予 | 2,526,000 | - | - | - | 40,600 | - | 23,800 | - |
| 2015.03 | 2015/05/11 | 実 | - | - | - | - | - | - | - | - |
| 2015.03 | 2015/04/28 | 修正予 | 2,421,000 | ↑ | - | - | 38,900 | ↑ | 22,800 | ↑ |
| 2015.03 | 2015/02/05 | Q3予 | 2,410,000 | → | 22,600 | → | 31,900 | → | 18,300 | → |
| 2015.03 | 2014/11/04 | Q2予 | 2,410,000 | → | 22,600 | → | 31,900 | → | 18,300 | → |
| 2015.03 | 2014/10/29 | 修正予 | 2,410,000 | ↓ | 22,600 | ↓ | 31,900 | ↓ | 18,300 | ↓ |
| 2015.03 | 2014/08/04 | Q1予 | 2,527,000 | → | 28,800 | → | 38,000 | → | 21,000 | → |
| 2015.03 | 2014/05/09 | 当初予 | 2,527,000 | - | 28,800 | - | 38,000 | - | 21,000 | - |
| 2014.03 | 2014/05/09 | 実 | 2,504,504 | ↑ | 34,964 | ↑ | 44,561 | ↑ | 25,566 | ↑ |
| 2014.03 | 2014/04/28 | 当初予 | 2,504,000 | - | 34,900 | - | 44,500 | - | 25,500 | - |
